Vivos Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vivos Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2024.
  • Vivos Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -96.2 %, a 29% increase year-over-year.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2023 was -125 %, a 19.8% increase from 2022.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2022 was -156 %, a 29.4% decline from 2021.
  • Vivos Therapeutics, Inc. annual Operating Margin for 2021 was -121 %, a 31% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -96.2 +39.4 +29% Apr 1, 2024 Jun 30, 2024
Q1 2024 -120 +23.8 +16.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -125 +30.9 +19.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -131 +29.2 +18.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -136 +22.5 +14.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -144 -5.84 -4.22% Jan 1, 2023 Mar 31, 2023
Q4 2022 -156 -35.5 -29.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -160 -38.8 -31.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -158 -51.4 -48.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -138 -41.5 -42.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -121 -28.6 -31% Oct 1, 2021 Dec 31, 2021
Q3 2021 -122 Jul 1, 2021 Sep 30, 2021
Q2 2021 -107 Apr 1, 2021 Jun 30, 2021
Q1 2021 -96.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -92.2 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.